136 related articles for article (PubMed ID: 38197482)
21. The miR-1290/OGN axis in ovarian cancer-associated fibroblasts modulates cancer cell proliferation and invasion.
Jiang B; Xiao S; Zhang S; Xiao F
J Ovarian Res; 2024 Feb; 17(1):52. PubMed ID: 38402185
[TBL] [Abstract][Full Text] [Related]
22. Hypoxic exosomal HIF-1α-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis.
Zeng Z; Zhao Y; Chen Q; Zhu S; Niu Y; Ye Z; Hu P; Chen D; Xu P; Chen J; Hu C; Hu Y; Xu F; Tang J; Wang F; Han S; Huang M; Wang C; Zhao G
Oncogene; 2021 Sep; 40(36):5505-5517. PubMed ID: 34294845
[TBL] [Abstract][Full Text] [Related]
23. Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK.
Patel GK; Khan MA; Bhardwaj A; Srivastava SK; Zubair H; Patton MC; Singh S; Khushman M; Singh AP
Br J Cancer; 2017 Feb; 116(5):609-619. PubMed ID: 28152544
[TBL] [Abstract][Full Text] [Related]
24. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
25. Cancer-associated fibroblasts derived extracellular vesicles promote angiogenesis of colorectal adenocarcinoma cells through miR-135b-5p/FOXO1 axis.
Dai X; Xie Y; Dong M
Cancer Biol Ther; 2022 Dec; 23(1):76-88. PubMed ID: 35100092
[TBL] [Abstract][Full Text] [Related]
26. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
[TBL] [Abstract][Full Text] [Related]
27. Extracellular vesicles derived from cancer-associated fibroblasts carry tumor-promotive microRNA-1228-3p to enhance the resistance of hepatocellular carcinoma cells to sorafenib.
Zhang Y; Pan Q; Shao Z
Hum Cell; 2023 Jan; 36(1):296-311. PubMed ID: 36424471
[TBL] [Abstract][Full Text] [Related]
28. Induction, modulation and potential targets of miR-210 in pancreatic cancer cells.
Chen WY; Liu WJ; Zhao YP; Zhou L; Zhang TP; Chen G; Shu H
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):319-24. PubMed ID: 22672828
[TBL] [Abstract][Full Text] [Related]
29. MiR-373-3p enhances the chemosensitivity of gemcitabine through cell cycle pathway by targeting CCND2 in pancreatic carcinoma cells.
Hu W; Liu Q; Pan J; Sui Z
Biomed Pharmacother; 2018 Sep; 105():887-898. PubMed ID: 30021382
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic cancer cell-derived microRNA-155-5p-containing extracellular vesicles promote immune evasion by triggering EHF-dependent activation of Akt/NF-κB signaling pathway.
Wang S; Gao Y
Int Immunopharmacol; 2021 Nov; 100():107990. PubMed ID: 34482266
[TBL] [Abstract][Full Text] [Related]
31. Hypoxic pancreatic stellate cell-derived exosomal mirnas promote proliferation and invasion of pancreatic cancer through the PTEN/AKT pathway.
Cao W; Zeng Z; He Z; Lei S
Aging (Albany NY); 2021 Feb; 13(5):7120-7132. PubMed ID: 33653966
[TBL] [Abstract][Full Text] [Related]
32. Monocytes educated by cancer-associated fibroblasts secrete exosomal miR-181a to activate AKT signaling in breast cancer cells.
Pakravan K; Mossahebi-Mohammadi M; Ghazimoradi MH; Cho WC; Sadeghizadeh M; Babashah S
J Transl Med; 2022 Dec; 20(1):559. PubMed ID: 36463188
[TBL] [Abstract][Full Text] [Related]
33. An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and hypoxia-inducible factor 1α-mediated up-regulation of CXCR4.
Arora S; Bhardwaj A; Singh S; Srivastava SK; McClellan S; Nirodi CS; Piazza GA; Grizzle WE; Owen LB; Singh AP
J Biol Chem; 2013 Jul; 288(29):21197-21207. PubMed ID: 23740244
[TBL] [Abstract][Full Text] [Related]
34. Vav1-dependent Rac1 activation mediates hypoxia-induced gemcitabine resistance in pancreatic ductal adenocarcinoma cells through upregulation of HIF-1α expression.
Zhu C; Hu H; Ma Y; Xiong S; Zhu D
Cell Biol Int; 2023 Nov; 47(11):1835-1842. PubMed ID: 37545183
[TBL] [Abstract][Full Text] [Related]
35. Extracellular vesicles-encapsulated microRNA-10a-5p shed from cancer-associated fibroblast facilitates cervical squamous cell carcinoma cell angiogenesis and tumorigenicity via Hedgehog signaling pathway.
Zhang X; Wang Y; Wang X; Zou B; Mei J; Peng X; Wu Z
Cancer Gene Ther; 2021 May; 28(5):529-542. PubMed ID: 33235271
[TBL] [Abstract][Full Text] [Related]
36. Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210.
Yang Z; Zhao N; Cui J; Wu H; Xiong J; Peng T
Cell Oncol (Dordr); 2020 Feb; 43(1):123-136. PubMed ID: 31713003
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells.
Mace TA; Collins AL; Wojcik SE; Croce CM; Lesinski GB; Bloomston M
J Surg Res; 2013 Oct; 184(2):855-60. PubMed ID: 23726431
[TBL] [Abstract][Full Text] [Related]
38. HIF-1α-regulated stanniocalcin-1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signaling pathway.
Zhao F; Yang G; Qiu J; Liu Y; Tao J; Chen G; Su D; You L; Zheng L; Zhang T; Zhao Y
Mol Carcinog; 2022 Sep; 61(9):839-850. PubMed ID: 35785493
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of miR-210 involved in epithelial-mesenchymal transition of pancreatic cancer cells under hypoxia.
Ni J; Zhou S; Yuan W; Cen F; Yan Q
J Recept Signal Transduct Res; 2019; 39(5-6):399-406. PubMed ID: 31875764
[No Abstract] [Full Text] [Related]
40. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]